Literature DB >> 31820275

Tuberous Sclerosis (tsc2+/-) Model Eker Rats Reveals Extensive Neuronal Loss with Microglial Invasion and Vascular Remodeling Related to Brain Neoplasia.

Viera Kútna1, Libor Uttl1, Robert Waltereit2, Zdenka Krištofiková1, Daniel Kaping1, Tomáš Petrásek1, Cyril Hoschl1,3, Saak V Ovsepian4,5.   

Abstract

Tuberous sclerosis complex (TSC) is a genetic disorder characterized by frequent noncancerous neoplasia in the brain, which can induce a range of severe neuropsychiatric symptoms in humans, resulting from out of control tissue growth. The causative spontaneous loss-of-function mutations have been also identified in rats. Herein, we studied histopathological and molecular changes in brain lesions of the Eker rat model carrying germline mutation of the tsc2 gene, predisposed to multiple neoplasias. Predominant subcortical tumors were analyzed, along with a rare form occurring within the pyriform lobe. The uniform composition of lesions supports the histochemical parity of malformations, with immunofluorescence data supporting their neuro-glial origin. Massive depletion of mature neurons and axonal loss were evident within lesions, with occasional necrotic foci implying advanced stage of pathology. Enrichment of mesenchymal-derived cell markers with hallmarks of neurogenesis and active microglia imply enhanced cell proliferation, with local immune response. The depletion of capillaries within the core was complemented by the formation of dense mesh of nascent vessels at the interface of neoplasia with healthy tissue, implying large-scale vascular remodeling. Taken as a whole, these findings present several novel features of brain tumors in Eker rat model, rendering it suitable for studies of the pathobiology and progression of primary brain tumors, with therapeutic interventions.

Entities:  

Keywords:  Eker rat; Glioma; Hamartomas; Microglial activation; Nascent capillaries; Neuro-oncology; Tuberous sclerosis complex

Mesh:

Substances:

Year:  2020        PMID: 31820275      PMCID: PMC7007483          DOI: 10.1007/s13311-019-00812-6

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  42 in total

1.  Modified Gilliam uterine suspension using laparoscopic visualization.

Authors:  J W Candy
Journal:  Obstet Gynecol       Date:  1976-02       Impact factor: 7.661

2.  Epidemiology of tuberous sclerosis.

Authors:  J P Osborne; A Fryer; D Webb
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

3.  Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis.

Authors:  A C Jones; C E Daniells; R G Snell; M Tachataki; S A Idziaszczyk; M Krawczak; J R Sampson; J P Cheadle
Journal:  Hum Mol Genet       Date:  1997-11       Impact factor: 6.150

Review 4.  A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).

Authors:  Petrus J de Vries; Lucy Wilde; Magdalena C de Vries; Romina Moavero; Deborah A Pearson; Paolo Curatolo
Journal:  Am J Med Genet C Semin Med Genet       Date:  2018-08-16       Impact factor: 3.908

5.  Novel cerebral lesions in the Eker rat model of tuberous sclerosis: cortical tuber and anaplastic ganglioglioma.

Authors:  M Mizuguchi; S Takashima; H Yamanouchi; Y Nakazato; H Mitani; O Hino
Journal:  J Neuropathol Exp Neurol       Date:  2000-03       Impact factor: 3.685

6.  Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis.

Authors:  R S Yeung; C D Katsetos; A Klein-Szanto
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

7.  Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations.

Authors:  Piotr Kozlowski; Penelope Roberts; Sandra Dabora; David Franz; John Bissler; Hope Northrup; Kit Sing Au; Ross Lazarus; Dorota Domanska-Pakiela; Katarzyna Kotulska; Sergiusz Jozwiak; David J Kwiatkowski
Journal:  Hum Genet       Date:  2007-02-08       Impact factor: 4.132

8.  Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease.

Authors:  R S Kandt; J L Haines; M Smith; H Northrup; R J Gardner; M P Short; K Dumars; E S Roach; S Steingold; S Wall
Journal:  Nat Genet       Date:  1992-09       Impact factor: 38.330

Review 9.  Tuberous sclerosis.

Authors:  Paolo Curatolo; Roberta Bombardieri; Sergiusz Jozwiak
Journal:  Lancet       Date:  2008-08-23       Impact factor: 79.321

10.  Autistic behaviour and attention deficits in tuberous sclerosis: a population-based study.

Authors:  I C Gillberg; C Gillberg; G Ahlsén
Journal:  Dev Med Child Neurol       Date:  1994-01       Impact factor: 5.449

View more
  3 in total

1.  mTOR inhibitor improves autistic-like behaviors related to Tsc2 haploinsufficiency but not following developmental status epilepticus.

Authors:  Tomas Petrasek; Iveta Vojtechova; Ondrej Klovrza; Klara Tuckova; Cestmir Vejmola; Jakub Rak; Anna Sulakova; Daniel Kaping; Nadine Bernhardt; Petrus J de Vries; Jakub Otahal; Robert Waltereit
Journal:  J Neurodev Disord       Date:  2021-04-17       Impact factor: 4.025

2.  RhoJ facilitates angiogenesis in glioblastoma via JNK/VEGFR2 mediated activation of PAK and ERK signaling pathways.

Authors:  Mei Wang; Chengfei Zhang; Qian Zheng; Zhijie Ma; Min Qi; Guangfu Di; Shizhang Ling; Haojun Xu; Bin Qi; Chengyun Yao; Hongping Xia; Xiaochun Jiang
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 3.  Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes.

Authors:  Viera Kútna; Valerie B O'Leary; Ehren Newman; Cyril Hoschl; Saak V Ovsepian
Journal:  Neurotherapeutics       Date:  2021-01-04       Impact factor: 7.620

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.